Brazil Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

BMI Industry View 7
SWOT 9
Political 11
Economic 12
Business Environment 14
Industry Forecast 16
Pharmaceutical Market Forecast 16
Table: Brazil Pharmaceutical Sales, Historical Data And Forecasts 17
Healthcare Market Forecast 18
Table: Brazil Healthcare Expenditure Trends, Historical Data And Forecasts 20
Table: Brazil Government Healthcare Expenditure Trends, Historical Data And Forecasts 20
Table: Brazil Private Healthcare Expenditure Trends, Historical Data And Forecasts 21
Economic Analysis 22
Table: Brazil - Economic Activity 28
Prescription Drug Market Forecast 29
Table: Brazil Prescription Drug Market Indicators, Historical Data And Forecasts 30
Patented Drug Market Forecast 31
Table: Brazil Patented Drug Market Indicators, Historical Data And Forecasts 32
Generic Drug Market Forecast 33
Table: Brazil Generics Drug Market Indicators, Historical Data And Forecasts 37
OTC Medicine Market Forecast 39
Table: Brazil Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 40
Pharmaceutical Trade Forecast 41
Table: Brazil Pharmaceutical Trade Data And Forecasts (US$mn) 44
Table: Brazil Pharmaceutical Trade Data And Forecasts (BRLmn) 44
Other Healthcare Data 45
Key Risks To BMI's Forecast Scenario 46
Industry Risk Reward Ratings 47
Table: Table: Americas Pharmaceutical Risk/Reward Ratings, Q213 47
Rewards 48
Risks 48
Market Overview 50
Industry Trends And Developments 52
Epidemiology 52
Healthcare Sector 55
Research & Development 58
Table: Brazilian Government's Partnership Deals With Multinationals 59
Biotechnology 62
Clinical Trials 68
Regulatory Development 69
Regulatory Regime 69
Intellectual Property Regime 71
Counterfeits 73
Compulsory Licensing 74
Pricing Regime 76
Reimbursement Regime 79
OTC Regulations 81
Advertising 83
Competitive Landscape 85
Table: Top 20 Pharmaceutical Companies In Brazil By Sales In 2010 85
Innovative Drugmakers 86
Generic Drugmakers 95
Table: Hypermarcas' Major Acquisitions, 2005-11 97
OTC Sector 99
Pharmaceutical Distribution Sector 100
Pharmaceutical Retail Sector 102
Company Profile 106
Aché/Biosintética 106
EMS Sigma 110
Eurofarma 113
Medley 115
Cristália 118
Sanofi 121
Pfizer 124
Merck & Co 128
Novartis 132
GlaxoSmithKline 136
Table: GSK'S STRONG COLLABORATIVE EFFORTS IN PUBLIC-PRIVATE PARTNERSHIPS (PPPS) IN BRAZIL 139
Roche 140
Demographic Forecast 143
Demographic Outlook 143
Table: Brazil's Population By Age Group, 1990-2020 ('000) 144
Table: Brazil's Population By Age Group, 1990-2020 (% of total) 145
Table: Brazil's Key Population Ratios, 1990-2020 146
Table: Brazil's Rural And Urban Population, 1990-2020 146
Glossary 147
Methodology 149
Methodology 149
Risk/Reward Ratings Methodology 149
Ratings Overview 150
Table: Pharmaceutical Business Environment Indicators 150
Weighting 151
Table: Weighting Of Components 151
Sources 151

Drug and Medication in Brazil